Comparing the safety and efficient drug among palonosetron ondansetron and granisetron to prevent vomiting after laparoscopic surgeries.
Phase 3
- Conditions
- Health Condition 1: Z768- Persons encountering health services in other specified circumstances
- Registration Number
- CTRI/2023/07/054961
- Lead Sponsor
- Madhu G
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who give valid inform consent and willing to participate in the study
ASA grade I/II patients
Age group of 18 to 60 years scheduled to undergo elective laparoscopic surgeries, under general anaesthesia.
Exclusion Criteria
Patient refusing to participate in the study
Any contraindication to the use of drug
ASA III or more,
Emergency procedure
Pregnant and lactating patients
Patients with history of motion sickness
Patients on steroid therapy, antiemetics or on treatment with other medication known to produce nausea and vomiting .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of a single dose of palonosetron versus ondansetron versus granisetron for the prevention of postoperative nausea & vomiting after laparoscopic surgeries.Timepoint: metric units by visual analog scale for the first 24 hours
- Secondary Outcome Measures
Name Time Method To study the requirement for rescue anti-emetic medications <br/ ><br> <br/ ><br>Timepoint: number of persons requiring anti emetics in metric terms for 24 hours in the post operative period